Alginic acid/aluminum hydroxide/magnesium trisilicate Drug Interactions
Currently displaying 96 drugs known to have a minor interaction with alginic acid / aluminum hydroxide / magnesium trisilicate.
- 17 major drug interactions
- 145 moderate drug interactions
- 96 minor drug interactions
Minor interactions with alginic acid / aluminum hydroxide / magnesium trisilicate
Note: Showing generic names only.
A
B
C
- capecitabine
- captopril
- carteolol
- carvedilol
- chlordiazepoxide
- chlorpromazine
- cimetidine
- clobazam
- clonazepam
- clorazepate
- cortisone
D
E
F
G
H
I
L
M
- mefenamic acid
- mesoridazine
- methdilazine
- methotrimeprazine
- methylprednisolone
- metoprolol
- midazolam
- moexipril
N
O
P
- penbutolol
- perindopril
- perphenazine
- pindolol
- ponatinib
- prednisolone
- prednisone
- prochlorperazine
- promazine
- promethazine
- propiomazine
- propranolol
Q
R
S
T
- temazepam
- thiethylperazine
- thioridazine
- ticlopidine
- timolol
- trandolapril
- triamcinolone
- triazolam
- trifluoperazine
- triflupromazine
- trimeprazine
U
V
W
Z
Alginic acid/aluminum hydroxide/magnesium trisilicate alcohol/food interactions
There is 1 alcohol/food interaction with alginic acid / aluminum hydroxide / magnesium trisilicate.
Alginic acid/aluminum hydroxide/magnesium trisilicate disease interactions
There are 2 disease interactions with alginic acid / aluminum hydroxide / magnesium trisilicate which include:
More about alginic acid / aluminum hydroxide / magnesium trisilicate
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antacids
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.